The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Mass spectrometry‐based metabolomics: applications to biomarker and metabolic pathway research
Abstract
Mass spectrometry‐based metabolomics has become increasingly popular in molecular medicine. High‐definition mass spectrometry (MS), coupled with pattern recognition methods, have been carried out to obtain comprehensive metabolite profiling and metabolic pathway of large biological datasets. This sets the scene for a new and powerful diagnostic approach. Analysis of the key metabolites in body fluids has become an important part of improving disease diagnosis. With technological advances in analytical techniques, the ability to measure low‐molecular‐weight metabolites in bio‐samples provides a powerful platform for identifying metabolites that are uniquely correlated with a specific human disease. MS‐based metabolomics can lead to enhanced understanding of disease mechanisms and to new diagnostic markers and has a strong potential to contribute to improving early diagnosis of diseases. This review will highlight the importance and benefit with certain characteristic examples of MS‐metabolomics for identifying metabolic pathways and metabolites that accurately screen for potential diagnostic biomarkers of diseases. Copyright © 2015 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Human Serum Metabolome (HUSERMET) Consortium, Dunn, W. B., Broadhurst, D., Begley, P., Zelena, E., Francis-McIntyre, S., Anderson, N., Brown, M., Knowles, J. D., Halsall, A., et al. (2011) · Nature Protocols · doi:10.1038/nprot.2011.335 · Cited by 3,294
Human metabolic phenotype diversity and its association with diet and blood pressure
Holmes, E., Loo, R. L., Stamler, J., Bictash, M., Yap, I. K. S., Chan, Q., Ebbels, T., De Iorio, M., Brown, I. J., Veselkov, K. A., et al. (2008) · Nature · doi:10.1038/nature06882 · Cited by 1,054
Discovery of phosphatidylcholines and sphingomyelins as biomarkers for ovarian endometriosis
Vouk, K., Hevir, N., Ribič-Pucelj, M., Haarpaintner, G., Scherb, H., Osredkar, J., Möller, G., Prehn, C., Rižner, T. L., & Adamski, J. (2012) · Human Reproduction · doi:10.1093/humrep/des152 · Cited by 143
Cited by
Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review
Wang, W., Zhou, H., & Liu, L. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.09.027 · Cited by 562
Salam, U., Ullah, S., Tang, Z.-H., Elateeq, A. A., Khan, Y., Khan, J., Khan, A., & Ali, S. (2023) · Life · doi:10.3390/life13030706 · Cited by 480
Stress Biomarkers in Biological Fluids and Their Point-of-Use Detection
Steckl, A. J., & Ray, P. (2018) · ACS Sensors · doi:10.1021/acssensors.8b00726 · Cited by 319
Advances in mass spectrometry-based metabolomics for investigation of metabolites
Ren, J.-L., Zhang, A.-H., Kong, L., & Wang, X.-J. (2018) · RSC Advances · doi:10.1039/c8ra01574k · Cited by 291
Self-citationMitochondrial medicine in the omics era
Rahman, J., & Rahman, S. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30727-x · Cited by 283
Metadata
- Authors
- Zhang, A., Sun, H., Yan, G., Wang, P., & Wang, X.
- Venue
- Biomedical Chromatography
- Publisher
- Wiley
- Published
- 2015-03-04
- Volume
- 30
- Issue
- 1
- Pages
- 7-12
- ISSN
- 0269-3879 (ISSN-L)
- 1099-0801
- OpenAlex
- W1517336748
- Cited by
- 190
- References
- 3
- FWCI
- 6.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mass spectrometry‐based metabolomics: applications to biomarker and metabolic pathway research. https://app.cochat.ai/papers/10.1002/bmc.3453
- The paper
- Zhang, A., Sun, H., Yan, G., Wang, P., & Wang, X. (2016). Mass spectrometry‐based metabolomics: applications to biomarker and metabolic pathway research. Biomedical Chromatography. https://doi.org/10.1002/bmc.3453
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.